slide1 n.
Skip this Video
Download Presentation
Main achievements and further developments

Loading in 2 Seconds...

play fullscreen
1 / 8

Main achievements and further developments - PowerPoint PPT Presentation

  • Uploaded on

10 th Stakeholders’ meeting 15 th of March, 2007. 2006 and beyond:. Main achievements and further developments. Overcoming HIV/AIDS epidemic in Ukraine (programme supported by the Global Fund). Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Main achievements and further developments' - lenore-trujillo

Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

10th Stakeholders’ meeting

15th of March, 2007

2006 and beyond:

Main achievements and further developments

Overcoming HIV/AIDS epidemic in Ukraine

(programme supported by the Global Fund)

Andriy Klepikov

Executive Director,International HIV/AIDS Alliance in Ukraine


Expenditure profile

Alliance’s expenditure structure within Global Fund Project:from 1 January 2006— 31December 2006


2006 key results:

  • 3730 people (3178 adults and 552 children) are receiving antiretroviral therapy;
  • 1836 (4487 cumulatively since 2004) HIV-positive pregnant women received ARV to prevent mother-to-child transmission of HIV before and during labour during 2006;
  • 436 opiate-dependent people are receiving substitution maintenance therapy;
  • the groups most vulnerable to HIV have access to prevention and information services, including over110,000 injecting drug users, over 15,000 women involved in commercial sex and over 29,000 of prisoners;
  • 406 medical institutions in all regions of Ukraine received medicines and other medical supplies


Key results:

  • Scaling up of ARV therapy has influenced declining in the AIDS mortality growth rate;
  • Introduction of the substitution maintenance treatment has demonstrated posive implications. The examples include:

- a number of clients survived from death while being on SMT;

- crime rate falls dramatically among SMT’s clients;

- Illegal drug business loses significant money income from drug users reoriented on SMT;

  • In the area of HIV prevention several promising innovations were started (pharmacy initiative, peer driven interventions, VCT with rapid tests, community centres);
  • Round 6 process had very positive implications for the R1 grant (incl. progress with the methadone registration, substantial increase in the national AIDS budget for 2007 etc.)



  • Several indicators were not met in 2006, particularly, the ones related to substitution maintenance treatment and prevention of mother-to-child transmission;
  • Lack of clear and consistent governmental policy in regard to sufficient rolling out of the substitution therapy maintenance treatment with methadone
  • In order to make an impact, HIV prevention efforts require more substantial funding over the next years
  • Over 2007 clear confidence should be built to pick up with governmental funding Round 1 activities related to ARV treatment and PMTCT


2007 targets

  • 5,040patients on ART (including 725 children)
  • 3,500IDUs on ST (850 of which also on ART);
  • 7,325pregnant women receive PMTCT (cumulative target starting 2004);
  • 24,500 PLHA access non-clinical care & support

(including 3,000 children)

  • 128,000 IDUs
  • 12,500sex workers access prevention services
  • 17,000 prisoners


Next steps

  • Harmonization with Round 6 programme and with resumed World Bank loan project as well as with other major interventions including national and locally funded programmes
  • Addressing programme challenges e.g. ARV treatment dropouts, growing needs in substitution therapy, and coverage of most at risk populations and PLHA
  • Year 5 planning (October 2007 – September 2008) including incorporation of the savings to bridge Round 6 timetable
  • Recommendations from the external evaluation of the grant will be applied for the current and Round 6 grants as well as for the overall country response